2006
DOI: 10.1016/j.fct.2005.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21Cip1 and p27Kip1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
26
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(29 citation statements)
references
References 40 publications
3
26
0
Order By: Relevance
“…1 shows that the extraction yield of epimedin C decreases in the order: CH 3 OH N C 2 H 5 OH N H 2 O N CH 3 CN. Moreover, it was reported that epimedin C isolated from the methanolic extract displayed immunomodulatory effect and possessed anti-tumor activity (Iinuma et al, 1990;Liu et al, 2006). Hence, methanol was chosen as the best solvent in the following extraction experiments.…”
Section: Solvent Typementioning
confidence: 99%
“…1 shows that the extraction yield of epimedin C decreases in the order: CH 3 OH N C 2 H 5 OH N H 2 O N CH 3 CN. Moreover, it was reported that epimedin C isolated from the methanolic extract displayed immunomodulatory effect and possessed anti-tumor activity (Iinuma et al, 1990;Liu et al, 2006). Hence, methanol was chosen as the best solvent in the following extraction experiments.…”
Section: Solvent Typementioning
confidence: 99%
“…Meanwhile, as the principal prenylflavonoid in Epimedium wushanense, epimedin C enhanced the response of spleen antibodyforming cells significantly [8]. Recent study also revealed its anti-tumor activity against hepatoma SK-Hep-1 cells [9].…”
Section: Introductionmentioning
confidence: 97%
“…18) There have also been several reports of other prenylflavonoids derived from Epimedium as an anticancer agent to MCF7 cells, 19,20) Hec1A cells, 21) PC-3 cells, 22) HEPG2 cells, 23,24) SMMC-7721 cells, 25) and SK-Hep-1 cells. 26) However, the paucity of literature y To whom correspondence should be addressed. Xiaoguang CHEN, Tel: +86-10-63165207; Fax: +86-10-63017757; E-mail: chxg@imm.ac.cn; Baolin GUO, Tel: +86-10-57833172; Fax: +86-10-57833288; E-mail: guobaolin010@163.com Abbreviations: AIF, apoptosis-inducing factor; BPB, bromophenol blue; PVDF, polyvinylidene fluoride; PI, propidium iodide; DAPI, 4 0 ,6-diamidino-2-phenylindole; JC-1, 5,5 0 ,6,6 0 -tetra-chloro-1,1 0 ,3,3 0 -tetra-ethylbenzimidazolyl-carbocyanine iodide; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PARP, poly (ADP-ribose) polymerase; TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis-inducing ligand; PAGE, polyacrylamide gel electrophoresis about the IcaS role in breast cancer prompted us to investigate this, and we observed that IcaS inhibited the proliferation of both MCF7 and MDA-MB-231 cells.…”
mentioning
confidence: 99%